Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Strata Skin Sciences Debt to Equity Ratio 2010-2024 | SSKN

Current and historical debt to equity ratio values for Strata Skin Sciences (SSKN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Strata Skin Sciences debt/equity for the three months ending December 31, 2024 was 3.06.
  
Strata Skin Sciences Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-12-31 $0.03B $0.01B 6.27
2024-09-30 $0.03B $0.01B 3.30
2024-06-30 $0.03B $0.01B 3.17
2024-03-31 $0.03B $0.01B 3.25
2023-12-31 $0.03B $0.01B 2.31
2023-09-30 $0.03B $0.02B 1.91
2023-06-30 $0.04B $0.02B 2.27
2023-03-31 $0.03B $0.02B 1.54
2022-12-31 $0.03B $0.02B 1.39
2022-09-30 $0.03B $0.02B 1.44
2022-06-30 $0.03B $0.02B 1.40
2022-03-31 $0.03B $0.02B 1.32
2021-12-31 $0.02B $0.03B 0.83
2021-09-30 $0.02B $0.03B 0.79
2021-06-30 $0.02B $0.03B 0.74
2021-03-31 $0.02B $0.02B 0.90
2020-12-31 $0.02B $0.03B 0.81
2020-09-30 $0.02B $0.03B 0.82
2020-06-30 $0.02B $0.03B 0.73
2020-03-31 $0.02B $0.03B 0.64
2019-12-31 $0.02B $0.03B 0.65
2019-09-30 $0.02B $0.03B 0.65
2019-06-30 $0.02B $0.03B 0.63
2019-03-31 $0.02B $0.03B 0.58
2018-12-31 $0.02B $0.03B 0.52
2018-09-30 $0.01B $0.03B 0.38
2018-06-30 $0.01B $0.03B 0.37
2018-03-31 $0.02B $0.02B 0.86
2017-12-31 $0.02B $0.02B 0.97
2017-09-30 $0.02B $0.02B 0.67
2017-06-30 $0.03B $0.01B 2.69
2017-03-31 $0.03B $0.01B 2.43
2016-12-31 $0.03B $0.02B 1.94
2016-09-30 $0.03B $0.02B 1.71
2016-06-30 $0.03B $0.02B 1.57
2016-03-31 $0.03B $0.02B 2.16
2015-12-31 $0.03B $0.02B 2.11
2015-09-30 $0.04B $0.02B 2.29
2015-06-30 $0.03B $0.03B 1.00
2015-03-31 $0.01B $0.01B 1.15
2014-12-31 $0.01B $0.01B 0.64
2014-09-30 $0.01B $0.02B 0.60
2014-06-30 $0.01B $0.01B 0.75
2014-03-31 $0.01B $0.01B 1.73
2013-12-31 $0.01B $0.01B 0.70
2013-09-30 $0.00B $0.01B 0.28
2013-06-30 $0.01B $0.02B 0.52
2013-03-31 $0.01B $0.02B 0.36
2012-12-31 $0.00B $0.01B 0.24
2012-09-30 $0.00B $0.02B 0.15
2012-06-30 $0.00B $0.02B 0.13
2012-03-31 $0.00B $0.02B 0.07
2011-12-31 $0.00B $0.03B 0.05
2011-09-30 $0.00B $0.02B 0.08
2011-06-30 $0.00B $0.02B 0.06
2011-03-31 $0.00B $0.03B 0.07
2010-12-31 $0.00B $0.03B 0.06
2010-09-30 $0.00B $0.04B 0.05
2010-06-30 $0.00B $0.03B 0.07
2010-03-31 $0.00B $0.03B 0.05
2009-12-31 $0.00B $0.03B 0.06
2009-09-30 $0.00B $0.03B 0.06
2009-06-30 $0.00B $0.01B 0.18
2009-03-31 $0.00B $0.01B 0.13
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.011B $0.034B
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $35.134B 48.53
Tempus AI (TEM) United States $6.966B 0.00
Hims & Hers Health (HIMS) United States $6.050B 97.25
Inspire Medical Systems (INSP) United States $4.470B 86.83
IRhythm Technologies (IRTC) United States $3.223B 0.00
Privia Health (PRVA) United States $2.873B 215.27
Schrodinger (SDGR) United States $1.881B 0.00
Clover Health Investments (CLOV) United States $1.839B 0.00
Enovis (ENOV) United States $1.825B 11.29
Omnicell (OMCL) United States $1.418B 30.59
Phreesia (PHR) United States $1.409B 0.00
Azenta (AZTA) United States $1.154B 53.72
10x Genomics (TXG) United States $0.918B 0.00
Butterfly Network (BFLY) United States $0.568B 0.00
Fulgent Genetics (FLGT) United States $0.551B 0.00
Talkspace (TALK) United States $0.450B 267.00
Veradigm (MDRX) United States $0.449B 0.00
Standard BioTools (LAB) United States $0.440B 0.00
TruBridge (TBRG) United States $0.363B 0.00
Claritev (CTEV) United States $0.325B 0.00
Health Catalyst (HCAT) United States $0.270B 0.00
Nyxoah SA (NYXH) Belgium $0.206B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.189B 0.00
Pulmonx (LUNG) United States $0.182B 0.00
American Well (AMWL) United States $0.109B 0.00
EUDA Health Holdings (EUDA) Singapore $0.100B 0.00
Retrieve Medical Holdings (RMHI) United States $0.082B 0.00
MDxHealth SA (MDXH) Belgium $0.076B 0.00
P3 Health Partners (PIII) United States $0.066B 0.00
111 (YI) China $0.064B 0.00
CareCloud (CCLD) United States $0.060B 2.58
HeartBeam (BEAT) United States $0.055B 0.00
Outset Medical (OM) United States $0.040B 0.00
Zepp Health (ZEPP) China $0.039B 0.00
Zhongchao (ZCMD) China $0.030B 0.00
Bullfrog AI Holdings (BFRG) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.014B 0.00
MSP Recovery (MSPR) United States $0.014B 0.00
Streamline Health Solutions (STRM) United States $0.010B 0.00
Healthcare Triangle (HCTI) United States $0.009B 0.00
Precipio (PRPO) United States $0.009B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
Movano (MOVE) United States $0.007B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Syra Health (SYRA) United States $0.001B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00